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Abstract
Background: HIV serosurveys have become important sources of HIV prevalence estimates, but
these estimates may be biased because of refusals and other forms of non-response. We investigate
the effect of the post-test counseling study protocol on bias due to the refusal to be tested.
Methods: Data come from a nine-month prospective study of hospital admissions in Addis Ababa
during which patients were approached for an HIV test. Patients had the choice between three
consent levels: testing and post-test counseling (including the return of HIV test results), testing
without post-test counseling, and total refusal. For all patients, information was collected on basic
sociodemographic background characteristics as well as admission diagnosis. The three consent
levels are used to mimic refusal bias in serosurveys with different post-test counseling study
protocols. We first investigate the covariates of consent for testing. Second, we quantify refusal
bias in HIV prevalence estimates using Heckman regression models that account for sample
selection.
Results: Refusal to be tested positively correlates with admission diagnosis (and thus HIV status),
but the magnitude of refusal bias in HIV prevalence surveys depends on the study protocol. Bias is
larger when post-test counseling and the return of HIV test results is a prerequisite of study
participation (compared to a protocol where test results are not returned to study participants,
or, where there is an explicit provision for respondents to forego post-test counseling). We also
find that consent for testing increased following the introduction of antiretroviral therapy in
Ethiopia. Other covariates of refusal are age (non-linear effect), gender (higher refusal rates in
men), marital status (lowest refusal rates in singles), educational status (refusal rate increases with
educational attainment), and counselor.
Conclusion: The protocol for post-test counseling and the return of HIV test results to study
participants is an important consideration in HIV prevalence surveys that wish to minimize refusal
bias. The availability of ART is likely to reduce refusal rates.
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Background
Progress in medical technology has brought rapid HIV
testing within reach of nationally representative surveys.
This has generated new prospects for resolving bias in HIV
prevalence estimates based on antenatal clinic (ANC) sen-
tinel surveillance data, or, for providing a new gold stand-
ard for HIV prevalence estimates altogether [1-5].
However, data from population-based surveys are also
subject to bias due to the exclusion of high risk groups
from the sampling frame, and non-response because of
population mobility and refusal. The association between
mobility and HIV infection has been documented exten-
sively [6-9]. In comparison, relatively little is known
about the relationship between refusal and HIV infection
in nationally representative surveys [2,3,5,10]. Several
small-scale studies in STD and antenatal clinics have con-
cluded that refusals are positively associated with HIV
infection [11-19]. Three studies remain inconclusive
about the nature of the relationship or suggest the oppo-
site pattern [20-22]. On aggregate, population-based sur-
veys are believed to underestimate true HIV prevalence,
but most studies have not been able to identify significant
bias due to testing refusal [5,9,23-27]. Two studies chal-
lenge that optimism [28,29].
A study design feature that may contribute to differences
in refusal bias is the protocol for post-test counseling and
the return of test results. Agreeing to post-test counseling
and the return of test results is often a prerequisite of study
participation in health facility-based studies. This con-
trasts with most population-based surveys that follow a
protocol in which respondents or clients do not receive
their HIV test results (e.g., Demographic and Health Sur-
veys). Instead, they are given a voucher for retesting at the
nearest Voluntary Counseling and Testing (VCT) center at
no cost (if the service is not already free of charge) [30]. In
early studies involving testing for HIV, the return of test
results was not usually an option because samples had to
be shipped to an off-site lab for analysis. With the increas-
ing availability and reliability of rapid tests, the return of
test results is now feasible in the same session in which
the specimens are collected. Because of the ethical pre-
scription that study participants should share in the bene-
fits of research [30], the pressure to provide post-test
counseling including the return of HIV test results in HIV
prevalence surveys is likely to increase in the future. There-
fore, it is important to assess how to accommodate this
guideline in the testing protocol while preserving or max-
imizing the external validity of the ensuing HIV preva-
lence estimates.
Using data from a health facility in Addis Ababa, we first
present covariates of testing refusal. Second, we quantify
refusal bias in HIV prevalence estimates under different
post-test counseling study protocols via regression models
that account for sample selection. A final noteworthy fea-
ture of our study is that antiretroviral therapy (ART) was
introduced in Ethiopia during the course of data collec-
tion, and that allows us to evaluate its impact on refusal
rates.
Methods
The data for this study come from prospective monitoring
of hospital admissions and outpatient visits which was
initiated at Zewditu Memorial Hospital in May 2003 and
continued for nine months. Zewditu Memorial Hospital
is a government facility in the inner city of Addis Ababa
and was one of the few hospitals with a VCT center of suf-
ficient capacity to accommodate our study. Initially, the
study covered the TB-HIV clinic (TB, ambulatory
patients), the medical emergency (ER), internal medicine
(IM), gynaecology (GY), and pediatric wards (PE). For
each patient, a ward nurse collected basic background
characteristics (age and sex) as well as the admission and
discharge diagnosis. One month into the study, the surgi-
cal ward (SU) was included and we added educational sta-
tus, religion, birthplace and marital status as background
variables on the data collection forms. After new patients
were identified, a VCT-nurse did pre-test counseling and
asked for written consent of the patient. For minors, con-
sent was obtained from the parent or guardian along with
the assent of the patient him- or herself.
Following pre-test counseling, patients had the option to
participate in the study with the return of HIV test results
and post-test counseling (consent level A), to participate
in the study without the return of test results or post-test
counseling (consent level B), or, to decline testing and
counseling altogether (consent level C). In the remainder
of this article, we refer to post-test counseling as the inter-
action between counselor and client that includes the
return of the test result and a counseling session tailored
to the HIV status of the client. The three consent levels
help us mimic refusal bias under different post-test coun-
seling study protocols: we consider consent level C to rep-
resent refusals in a protocol where post-test counseling is
not offered to respondents (or where an explicit provision
exists to test without post-test counseling), and we com-
bine consent levels B and C to represent refusals in a pro-
tocol where post-test counseling is a requirement of study
participation.
After consent was obtained, the VCT-nurse administered a
Determine Rapid HIV1-2 test. Capillus™ HIV-1/HIV-2
confirmatory tests were done on positive samples, and if
the outcomes of these tests were discrepant a Uni-Gold™
HIV test was done as a tie breaker. Tests were offered free
of charge. Nine VCT nurses carried out counseling and
anywhere between two and four nurses covered each
ward. All but one of the counselors were female.BMC Public Health 2009, 9:163 http://www.biomedcentral.com/1471-2458/9/163
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To study whether refusals are more common among
patients with a higher likelihood of infection, we rely on
the admission diagnosis because (1) it is correlated with
HIV status, and (2) also observed for patients who were
not tested. We use admission rather than discharge diag-
nosis because it is less likely to be influenced by the test
result itself. The availability of information on the medi-
cal condition of respondents constitutes an important
advantage of a medical facility-based sample. In contrast,
most measured traits correlate weakly with HIV status in
community-based studies, and that renders assessments
of refusal bias in HIV prevalence estimates questionable.
The downside of a medical facility-based study is that it is
not necessarily representative of the determinants of par-
ticipation in population-based surveys (e.g., levels of -
undisclosed- prior knowledge of one's HIV status may be
higher in a health facility sample, and prior knowledge of
HIV positive status has been identified as a source of bias
in HIV prevalence estimates [29]). Therefore, our esti-
mates of the degree of refusal bias cannot be extrapolated
to general population surveys, but a health facility-based
sample is probably satisfying to identify the type of post-
test counseling protocol that minimizes bias (i.e., to iden-
tify the relative magnitude of refusal bias under different
study protocols).
All admission diagnoses were coded using the Interna-
tional Classification of Diseases (ICD-10) [31]. Coders
did not have access to HIV status information. For each
entry in Table 1, we calculated the HIV prevalence among
Table 1: Admission diagnoses and likelihood of infection. Zewditu Memorial Hospital, Addis Ababa (2003–04, age 16 and above)
% HIV+ N ICD-10 code
Diarrhoea and GE of presumed infectious origin 66.7 42 A09
Respiratory TB 69.7 33 A15–16
Other TB 60.0 15 A17–19
HIV 100.0 2 B2
Malaria 17.1 35 B50–54
Herpes zoster, oral candiasis, toxoplasmosis and PCP 94.7 38 B02, B37, B58–59
Other infectious and parasitic diseases 14.0 43 A01, A03, A07, A30, A35, A41, A63–64, A68, A75, A82, B45
Neoplasm's of breast, cervix, uterus and leiomyoma 14.6 48 C50, C53–55, D25–26
Other neoplasms (benign and malignant) 0.0 25 C0, C2–4, C51–52, C56–58, C6–9, D0, D22–24, D3–4
Thyroid disorders 9.9 71 E00–05
Diabetes and hypoglycemia 11.1 27 E10–E16
Diseases of the nervous system (mainly meningitis) 35.7 14 G00, G03–04, G25, G40, G54
Hypertension 7.1 28 I10–I13
Hypotension 61.9 21 I95
Other diseases of the circulatory system 6.7 45 I05, I09, I15, I21, I31, I38, I49–51, I61, I63–64, I80, I83–I84, I86, 
I88
Pneumonia 30.6 36 J18
Other diseases of the respiratory system 26.9 26 J11, J44–46, J86, J90, J93–94, J98
Gastritis and other diseases of the oesophagus, stomach and 
duodenum
15.0 60 K27, K29–31
Diseases of the appendix 9.0 78 K35, K37–38
Hernia and intestinal obstruction 5.7 70 K40, K42–43, K46, K56
Cholelithiasis and diseases of the pancreas 6.1 132 K80, K82, K85–K86
Other diseases of the digestive system 15.8 38 K04, K12, K60, K62–63, K65–66, K72–73, K75–76, K83, K91–
93
Diseases of the skin and subcutaneous tissue 22.2 9 L, M
Glomerular diseases and diseases of the urinary system 13.6 22 N0–3
Diseases of male genital organs 2.6 38 N4
Inflammatory diseases of female pelvic organs and disorders of 
the female genital tract
20.0 25 N7–9
Complications of pregnancy and delivery 15.9 44 O
Fever of unknown origin 32.7 104 R50
Chronic illness 79.3 29 R69
Symptoms signs and abnormal clinical findings not elsewhere 
specified
17.5 63 R0–4, R56–58, R62
External causes and injuries 7.7 39 S, T, X
Other and unknown admission diagnoses 12.9 31 A80, B19, B56, D5–8, E15, E40–42, E55, E83, E86, E88, K36, 
P07, Q43, Q53, U, Z4
Total 22.2 1331BMC Public Health 2009, 9:163 http://www.biomedcentral.com/1471-2458/9/163
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those who agreed to test. These percentages measure the
likelihood of infection, and are used as a predictor of con-
sent. We thus assume that within each group of condi-
tions listed in Table 1, HIV status is not correlated with the
willingness to be tested (e.g., that the HIV prevalence in
patients with pneumonia is the same for those who
accepted and those who refused the test). We use the like-
lihood of infection variable rather than dummies for the
admission diagnoses for simplicity. Substituting one for
the other does not change the substantive conclusions
from this study. The pseudo R2 in a logistic regression of
HIV status on the likelihood of infection is 0.25.
The likelihood of infection as measured by the admission
diagnosis is first used as a predictor in logistic regression
models with the consent level as the outcome. In these
models, we verify whether the effect of the infection like-
lihood persists while controlling for other characteristics
of the respondent. In the next step, we estimate refusal
bias in HIV prevalence via a comparison of observed HIV
prevalence estimates and predicted values generated by
Heckman probit models that account for sample selection
[32-34]. The Heckman sample selection model corrects
for the possibility that HIV prevalence is different in
respondents who refuse testing. More formally, the Heck-
man sample selection model is a two-equation model
consisting of a regression and a selection equation that are
simultaneously estimated. The regression equation pre-
dicts HIV status: y = Xβ + u1 where X is a vector of covari-
ates. The selection equation specifies that HIV status is
only observed if Zγ + u2 > 0. In this equation Z stands for
a vector of characteristics that affect consent for HIV test-
ing. The error terms in both equations are assumed to be
normally distributed. Ordinary probit estimates of the
parameters in the regression equation are biased when ρ
(the correlation between u1 and u2) is not zero. The Heck-
man selection model lets us use information for patients
who refused the HIV test (e.g., counselor, admission diag-
nosis, and other sociodemographic background character-
istics) to improve estimates of parameters in the
regression model, and thus improve estimates of HIV
prevalence (i.e., the mean predicted value).
We limit the study population in four respects. The first set
of excluded cases is multiple admissions of the same indi-
vidual. We only consider first admissions because higher
order admission diagnoses might be influenced by the test
outcome at first visit, and thus introduce problems of
reverse causality. For the same reason, we exclude individ-
uals who volunteered their HIV status. The third excluded
category is patients under 16 years old, primarily because
we wish to restrict our study population to an age range
that is common in seroprevalence surveys. The TB/HIV
clinic constitutes another special case. HIV testing is
standard practice in diagnosing patients of the TB/HIV
clinic and some are referred to it precisely for that reason.
The TB/HIV clinic of Zewditu Memorial Hospital was also
one of the pioneering ART facilities in Ethiopia, which
contributes to the (self-) selection of patients.
Ethics
The study protocol was approved by the Research and
Publications Committee of the Addis Ababa University
Faculty of Medicine and received ethics clearance from the
Ethiopian Science and Technology Agency, and the Insti-
tutional Review Board of the University of Pennsylvania.
Written informed consent was obtained for administering
and using the HIV test results for research purposes. No
individual informed consent was requested for using
(anonimized) background characteristics and the admis-
sion diagnosis of patients who refused the HIV test.
Results
Study descriptives
In total 2719 individuals were approached. After exclud-
ing the TB/HIV clinic patients and those under 16 years,
1650 cases were retained (Table 2). Fifty-four of them
were discharged prior to testing and 49 already knew their
HIV status. These cases are omitted from further analysis.
Of all patients approached, 86.1% consented to testing
(consent levels A and B), and 75.5% chose testing fol-
lowed by a post-test counseling session (consent level A).
The percentage of total refusals (13.9%, consent level C)
is of the same magnitude as those observed in the DHS
involving serostatus testing in Mali, Kenya and Zambia
Table 2: Consent for testing and HIV status (Zewditu Memorial Hospital, Addis Ababa, 2003–04)
Freq. Column % Study participants (column %) HIV prevalence
Consent level A (testing & post-test counseling) 1168 70.8 75.5 27.5
Consent level B (testing only) 164 9.9 10.6 49.6
Consent level C (total refusal) 215 13.0 13.9 unknown
Known HIV status 49 3.0 excluded 81.8
Discharged/expired prior to testing 54 3.3 excluded
Total 1650 100BMC Public Health 2009, 9:163 http://www.biomedcentral.com/1471-2458/9/163
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[5]. Of those in consent levels A and B, 29.7% tested pos-
itive. The share of positives is markedly higher among
those who declined post-test counseling (consent level B,
49.6%) compared to those who agreed to testing and
post-test counseling (consent level A, 27.5%).
Covariates of consent
Table 3 shows associations between patients' background
characteristics and consent. A three-category variable for
religion (Orthodox Christian, Muslim and other), and a
dichotomous variable for place of birth (Addis Ababa ver-
sus elsewhere) are weak and statistically insignificant pre-
dictors of consent and therefore not shown. The age
effects are suggestive of an inverse U-shaped pattern with
refusals peaking in middle-aged adults. Refusal rates also
co-vary by marital and educational status. The most pro-
nounced variability in consent is, however, not by patient
characteristics, but by ward and counselor. The first is pos-
sibly related to the reason for admission (and thus HIV
status), but could be confounded by the variable success
of counselors in enrolling study participants. Several
counselors have refusal rates (consent level C) below
10%. For others, the refusal rate varies between 20 and
43%. Refusals also declined following the introduction of
ART.
Particularly relevant for the analysis of bias in HIV-preva-
lence estimates is the association between the likelihood
of infection and refusal: consent for testing and post-test
counseling (consent level A) drops from over 83% in
patients with the lowest likelihood of infection to just
under 70% among those with the highest likelihood of
infection. This is partly compensated by an increasing
share of patients who consented to testing without post-
Table 3: Covariates of consent for HIV testing (Zewditu Memorial Hospital, Addis Ababa, 2003–04)
Consent level (row %) Consent level (row %)
Agea AB C T o t a l Counselorb AB C T o t a l
16–19 86.0 4.7 9.4 107 1 57.5 13.7 28.8 73
20–29 73.9 11.7 14.5 498 2 91.4 5.0 3.6 303
30–39 68.7 14.1 17.2 396 3 53.6 3.6 42.9 28
40–49 77.3 9.7 13.0 247 5 73.2 26.8 0.0 41
50–59 77.5 10.6 12.0 142 6 0.0 0.0 100.0 2
60+ 85.9 3.9 10.3 156 7 98.5 0.3 1.2 322
Pearson Chi2(10) = 28.99 p < .01 8 63.1 16.6 20.3 728
Missing 100.0 0.0 0.0 1 9 56.0 10.0 34.0 50
Pearson Chi2(14) = 276.27, p < .01
Education
Illiterate 82.3 10.2 7.5 362 Ward
1–6th grade 76.5 11.8 11.8 272 ER 76.2 13.9 9.9 625
7–12th grade 76.0 11.0 13.0 607 GY 55.2 9.5 35.3 201
>12th grade 61.2 10.9 27.9 129 IM 57.7 20.6 21.7 97
Pearson Chi2(8) = 37.46 p < .01 SU 84.1 6.1 9.8 624
Missing 68.9 7.9 23.2 177 Pearson Chi2(6) = 134.44, p < .01
Marital status Study montha
Single 78.6 11.6 9.8 481 Prior to ART 64.0 16.2 19.8 445
Mar 76.5 9.0 14.6 769 Since ART 80.1 8.4 11.5 1,102
Div/wid 69.5 17.8 12.7 118 Pearson Chi2(2) = 44.72, p < .01
Pearson Chi2(4) = 14.49, p < .01
Missing 67.0 10.1 22.9 179 Gender
Female 75.3 9.9 14.7 876
Likelihood of infectiona Male 75.7 11.5 12.8 671
≤ 7.49 83.5 6.4 10.1 376 Pearson chi2(2) = 1.86, p = 0.40
7.5 – 14.9 79.0 8.6 12.5 409
15.0 – 29.9 69.4 10.6 20.0 376
≥ 30 69.9 16.9 13.3 385
Pearson Chi2(6) = 44.05, p < .01
Missing 0.0 100.0 0.0 1
Notes:
a In the regression models in Tables 4 and 5, age is defined in terms of single year age groups and study month is coded 0 for the period prior to the 
introduction of ART and consecutive numbers for months that followed. HIV likelihood is used as the proportion HIV+ for each ICD-10 entry in 
Table 1. The other variables are defined as shown in the table.
b Counselor #4 only worked in the TB/HIV clinic and omitted from this table and any subsequent analysis. Counselor 6 worked primarily in the 
pediatrics ward.BMC Public Health 2009, 9:163 http://www.biomedcentral.com/1471-2458/9/163
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test counseling (consent level B) as the likelihood of infec-
tion increased.
To explore the relationship between refusal and its predic-
tors in a multivariate context, we use logistic regression
models with the consent level as the outcome of interest
(Table 4). In the first binary logistic model (consent levels
B and C versus A), the likelihood of being HIV positive is
correlated with consent for testing and post-test coun-
seling and highly significant: for each percentage point
increase in the likelihood of infection, the odds to consent
to testing and post-test counseling (consent level A)
decrease by 1.5%. The analysis also confirms that coun-
selors had variable success in obtaining consent. Of fur-
ther interest is that refusals gradually declined following
the introduction of ART. In Model 2, we introduce a
number of additional control variables (i.e., ward of
admission, male gender, age, educational level and mari-
Table 4: Binary and multinomial logistic regressions predicting refusal of testing for HIV (Zewditu Memorial Hospital, Addis Ababa, 
2003–04)
Binary logistic regression predicting refusal
(exp(b) or odds ratios)
Multinomial logistic regression predicting refusal
(exp(b) or relative risk ratios)
B & C versus A B versus A C versus A B versus A C versus A
Model 1 Model 2 Model 3 Model 4
Likelihood of infection 1.01** 1.01** 1.02** 1.01** 1.01** 1.01**
Counselor (vs #1)
Counselor 2 0.07** 0.07** 0.12** 0.05** 0.06** 0.09**
Counselor 3 0.46 - 0.09** 0.71 - -
Counselor 5 0.50 0.33 1.58 - 1.48 -
Counselor 6 - - - - - -
Counselor 7 0.01** 0.01** 0.01** 0.02** 0.00** 0.01**
Counselor 8 0.46** 0.44 0.56 0.42** 0.26 0.68
Counselor 9 0.65 0.56 0.43 0.78 0.38 0.76
Study month (vs period prior to ART) 0.82** 0.81** 0.78** 0.84** 0.73** 0.88*
Ward (vs ER)
GY 1.23 0.44 2.68**
IM 1.42 0.56 2.73**
SU 0.83 0.60 1.04
Male 1.96** 1.68** 2.30**
Age 1.05 1.13** 1.02
Age squared .999* .998** 1.00
Education (vs no schooling)
Grade 1–6 1.33 1.16 1.57
Grade 7–12 1.27 0.79 1.95**
> 12th grade 1.70* 0.82 2.85**
Marital status (vs never married)
Married 1.44* 1.15 1.71**
Sep/Div/Wid 1.92* 1.78 2.03
N 1544 1357" 1546 1359
LR chi2 (df) 354.57(8) 364.68(18) 406.49(18) 453.04(38)
Prob > chi2 0.00 0.00 0.00 0.00
Pseudo R2 0.21 0.25 0.18 0.24
Log likelihood -680.93 -554.13 -917.05 -732.04
Notes:
* p ≤ .10; ** p ≤ .05
See Table 3 and the notes to that table for a definition of the explanatory variables. Other variables that were controlled for, but omitted in the final 
models because they lack statistical significance are: birth region (Addis Ababa versus other); religion (Orthodox Christian versus other); a squared 
term for likelihood of infection; an interaction between the likelihood of infection and study month; an interaction between birth region and sex. 
Because education and marital status were only introduced as additional variables in the second month of the study, models two and four are based 
on fewer cases.BMC Public Health 2009, 9:163 http://www.biomedcentral.com/1471-2458/9/163
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tal status). The odds to consent to testing and post-test
counseling are twice as high for women as for men. The
quadratic effect of age corroborates the curvilinear rela-
tionship between age and consent described in Table 3.
Those with higher educational status are less likely to par-
ticipate in testing, which also supports the bivariate
results. In terms of marital status, singles are most likely to
consent to testing and post-test counseling. The parameter
estimates for the infection likelihood, counselor, and
study month, however, hardly change in the presence of
these controls.
Breaking down the outcome by level of consent (models
3 and 4) changes little in terms of the substantive conclu-
sions compared to the binary logistic regression models.
The most noteworthy differences are that age is a weak
predictor of total refusal (consent level C versus A), and
that educational status does not have an effect in the equa-
tion predicting testing without versus testing with post-
test counseling (consent level B versus A). The parameters
for marital status point in the same direction as in the
binomial model but vary in their significance level.
Bias in HIV prevalence estimates
To quantify refusal bias in HIV prevalence estimates, we
turn to Heckman sample selection models of HIV preva-
lence. We use a Heckman probit model to generate pre-
dicted values of HIV prevalence, and compare these with
estimates from standard probit models. All explanatory
variables in models 2 and 4 of Table 4 are used in the
selection equation of the Heckman model. The Heckman
regression equation predicting HIV status includes age, a
squared term for age, sex, the likelihood of being HIV pos-
itive, and marital status. These variables are of little sub-
stantive interest in this study, and are simply chosen to
maximize the predictive power of the regression equation.
Table 5 presents HIV prevalence estimates based on stand-
ard probit models and Heckman probit models under dif-
ferent scenarios. The bottom row shows the likelihood
ratio (LR) test for the hypothesis that the error terms in the
regression and selection equations are uncorrelated (H0: ρ
= 0), or, in other words, that selection bias in negligible.
In the first column we present a simple empirical test of
the Heckman model. Here we assume that we do not have
information on HIV status for those who agreed to test but
declined post-test counseling (consent level B), and we
predict HIV prevalence in the sample consisting of indi-
viduals in consent levels A and B only using an ordinary
probit model and a probit model that accounts for sample
selection. Because we know the HIV prevalence in the
total sample, we can compare the probit estimates with
observed HIV prevalence. The ordinary probit estimate of
HIV prevalence is 17.7%, the selection model establishes
HIV prevalence at 23.1%, and the true or observed value
is 22.2%. Heckman estimates are thus more accurate than
standard probit estimates of HIV prevalence. The LR test
confirms that selection bias is significant.
It is noteworthy that ρ = 0 for a Heckman model that only
includes basic sociodemographic background characteris-
tics (sex, age, marital status, and education) in the selec-
tion equation (not shown). That model also
underestimates HIV prevalence. Adding counselor to the
selection equation renders ρ ≠ 0, but significantly overes-
timates HIV prevalence. Inclusion of information on the
health status of patients – an indicator that correlates well
with HIV status and consent for testing – thus considera-
bly improves Heckman predictions of HIV prevalence.
This sensitivity analysis confirms an earlier finding that
the validity of Heckman estimates are subject to the spec-
ification of the selection equation [34]. The specification
used in this application, however, produces good esti-
mates of HIV prevalence.
Table 5: Comparison of HIV seroprevalence estimates based on standard probit models and models accounting for sample selection 
under various scenarios (Zewditu Memorial Hospital, Addis Ababa, 2003–04)
Scenario
Test of Heckman modela Post-test counseling is required Post-test counseling is optional
E(HIV% – Probit) 17.7
(16.4 – 19.1)
17.8
(16.6–19.1)
21.4
(20.2–22.7)
E(HIV% – Heckman) 23.1
(21.7 – 24.4)
23.4
(22.1–24.7)
23.7
(22.4–25.0)
Observed HIV% 22.2
(19.9 – 24.4)
unknown unknown
Sample Consent groups A and B All consent groups All consent groups
Assumption HIV status in consent group B is 
unobserved
HIV status in consent groups B and C is 
unobserved
HIV status in consent group C is 
unobserved
LR test H0:ρ = 0 p < .01 p < .01 p = .07
Notes: 95%- CI are reported between brackets. Using dummies for admission diagnosis rather than the likelihood of infection in these regressions 
hardly changes the estimated prevalence rates though one of the selection models did not converge.
a In the first column, we assume that HIV status in consent group B is unknown, and compare the ordinary Probit and Heckman selection model 
estimate with the true or observed value of HIV prevalence.BMC Public Health 2009, 9:163 http://www.biomedcentral.com/1471-2458/9/163
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The last two columns compare HIV estimates for two
plausible study protocols. Bias in prevalence estimates is
substantial if response is dichotomized into refusal or full
participation without the option of testing without post-
test counseling (column 2). This scenario is most typical
for clinical intervention studies. Bias is much smaller, and
only marginally statistically significant, when the study
protocol explicitly allows participants to opt out of post-
test counseling and the return of HIV test results. This is
shown in the third column. This scenario is more typical
for population-based serosurveys.
Discussion
Our analyses establish that consent for testing is corre-
lated with the likelihood of HIV infection (assessed in
terms of the diagnosis at admission): patients who agree
to testing with or without post-test counseling (consent
levels A and B) are less likely to be infected than those
who refuse an HIV test (consent level C). This relationship
implies that testing refusal constitutes a potential source
of bias in HIV prevalence estimates. Regression methods
that account for sample selection confirm this, but quali-
fication is required in two respects. First, our study is
based on a hospital population and demands confirma-
tion in a more general sample. Second, much seems to
depend on the study protocol and informed consent pro-
cedures. In this sample, bias is limited if respondents are
offered the opportunity to opt out of post-test counseling
and the return of test results.
Because most population-based surveys utilize a testing
protocol that does not necessarily involve post-test-coun-
seling and the return of test results, they are less likely to
be affected by refusal bias than studies where post-test
counseling is a requirement for study participation. This
does not mean, however, that HIV prevalence estimates
from population-based serosurveys are free of bias. First,
we identified marginally significant bias under the
assumptions of a protocol whereby test results are not
returned to respondents. Second, bias may result from
other sources than those studied here (e.g., limitations of
the sampling frame and other forms of non-response).
Although this paper has focused on the relationship
between the likelihood of infection and consent for test-
ing, it is not the most important predictor of consent. The
largest variation in consent is produced by the counselors,
which suggests that studies interested in minimizing non-
response must be careful in the selection and training of
their fieldwork team. Unfortunately our study was not
designed to assess the possible reasons for the variable
study enrollment rates by counselor (e.g., via the rand-
omization of counselors across wards). We have no rea-
son, however, to suspect significant bias in HIV
prevalence estimates due to variability in consent attribut-
able to counselors. Another covariate of consent is the
availability of ART. In our study, the odds to consent for
testing and counseling increased by about 20% per month
following the launch of a governmental ART program. The
absence of a control group, however, does not allow us to
exclude other factors that may be responsible for this asso-
ciation. The finding that patients are more likely to agree
to testing once treatment becomes available is nonethe-
less plausible, and confirms findings from another obser-
vational study [35].
Conclusion
The protocol for post-test counseling and the return of
HIV test results to study participants is an important deter-
minant of consent for testing, and should be carefully
evaluated in studies that wish to minimize refusal bias in
HIV prevalence surveys. For the sake of scientific accuracy,
it is recommended to provide a modality to test without
post-test counseling when introducing the study protocol
to respondents. In studies where there is a long wait
between testing and the availability of test results, this is
often a de-facto option. As technological advances in
rapid testing methods reduce the waiting time, however,
this will become a consideration of increasing impor-
tance. To date, most population-based serosurveys have
followed a protocol that did not involve the return of HIV
test results. To the extent that our findings can be extrapo-
lated to non health facility-based settings, this study sug-
gests that in doing so, these surveys have avoided a
potentially important source of bias. Finally, we find that
the availability of ART is likely to reduce refusal rates, and
thus the potential for refusal bias.
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